Generics

Elemental Impurities – Their Impact on Drug Quality

While manufacturers have to ensure the quality and consistency of ingredients that go into a final pharmaceutical product, they must also employ measures for the proper control of unwanted impurities in drugs and drug ingredients.

Today, approximately 80% of all active pharmaceutical ingredients in medicines sold in the U.S. are manufactured in another part of the world. While manufacturers have to ensure the quality and consistency of ingredients that go into final pharmaceutical products, they must also employ measures for the proper control of unwanted impurities in drugs and drug ingredients.

Share

USP Congratulates Margaret Hamburg on Her Successful Tenure at the FDA

USP Congratulates Margaret Hamburg

Margaret Hamburg is approaching the end of a successful six-year tenure as Commissioner of the U.S. Food and Drug Administration. USP extends its congratulations to Dr. Hamburg in this letter from CEO Ron Piervincenzi.

Share

Ensuring the Quality of Synthetic Peptides

The global pharmaceutical landscape continues to evolve

Today, peptides represent one of the fastest growing segments in the pharmaceutical market. Hence, being able to manufacture peptides that are consistent in makeup and quality is an important priority for manufacturers of this drug class. This article discusses how the global pharmaceutical landscape continues to transform and how quality standards will play a growing role in the manufacture of these drugs.

Share

Pages